UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 9, 2007
ECOLAB INC.
(Exact name of registrant as specified in its charter)
Delaware
1-9328
41-0231510
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
370 Wabasha Street North, Saint Paul, Minnesota
55102
(Address of principal executive offices)
(Zip Code)
Registrants telephone number, including area code 651-293-2233
(Not applicable)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On November 9, 2007, Ecolab Inc. (Ecolab) announced that it completed its acquisition of Microtek Medical Holdings, Inc. (Microtek). The acquisition was consummated pursuant to the terms of the Merger Agreement, dated as of August 7, 2007 (the Merger Agreement), by and among Ecolab, Microtek, and Magic Acquisition Inc., a newly formed Georgia corporation and wholly owned subsidiary of Ecolab (Merger Sub). Pursuant to the Merger Agreement, Merger Sub merged with and into Microtek (the Merger), with Microtek continuing as the surviving corporation and a wholly owned subsidiary of Ecolab. All of the outstanding shares of Microtek were acquired by Ecolab in the Merger for $6.30 per share in cash. The purchase price for the acquisition of Microtek was funded by the issuance and sale by Ecolab of commercial paper under its U.S. commercial paper program pursuant to an exemption from registration under federal and state securities laws.
A copy of the News Release issued by Ecolab in connection with the acquisition is attached as Exhibit (99), and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
(99) Ecolab Inc. News Release dated November 12, 2007
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 12, 2007
By:
/s/Sarah Z. Erickson
By: Sarah Z. Erickson Its: Assistant Secretary
3
EXHIBIT INDEX
Exhibit No.
Description
Method Of Filing
(99)
Ecolab Inc. News Release dated November 12, 2007
Filed herewith electronically.
4
More Ecolab Inc News Articles
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.